Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00092872 | A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED) | PHASE3 | COMPLETED | 359 | — | — | Nov 1, 2003 | Feb 1, 2005 | Jan 30, 2015 | - | — |
| NCT00092859 | A 2-Year Study of an Investigational Drug in Obese Patients (0557-011) | PHASE3 | COMPLETED | 1,500 | — | — | Aug 1, 2003 | Jun 1, 2005 | Jan 2, 2017 | - | — |
| NCT00533481 | Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED) | PHASE2 | COMPLETED | 497 | — | — | Feb 1, 2004 | Dec 1, 2004 | Sep 16, 2016 | - | — |
| NCT00533598 | A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED) | PHASE2 | COMPLETED | - | — | — | Sep 1, 2002 | Jun 1, 2003 | Sep 7, 2016 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0557 | DRUG | - |
Inclusion Criteria: * Obese men and nonpregnant women between the ages of 18 and 65 years with a body mass index (height to weight ratio) as required by the study. Exclusion Criteria: * Patients with uncontrolled high blood pressure and/or diabetes mellitus (high blood sugar)